2009 News

October 28, 2009

Morphotek, Inc. Announces a Licensing Deal with Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody
Read More

September 23, 2009

Morphotek, Inc. Awarded Funding to Develop Therapeutic Antibodies Against Potential Biowarfare Toxins
Read More

August 25, 2009

Ovarian Cancer Patients Given True Gift of Happiness
Read More

July 15, 2009

Morphotek, Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies
Read More

July 1, 2009

Morphotek, Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
Read More

May 19, 2009

Morphotek, Inc and Lonza Group LTD Enter Into Manufacturing Services Agreement
Read More

March 25, 2009

Human Genome Sciences and Morphotek, Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology
Read More

January 14, 2009

Morphotek, Inc. Announces Evaluation Agreement with The University Hospital Heidelberg
Read More